Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Cymbalta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Cymbalta was produced by Lilly and Shionogi.

AZ pushes on with depression drug despite missing phase III endpoint

s Seroxat or serotonin/norephinephrine reuptake inhibitors (SNRIs) like Lilly's Cymbalta.

Lilly’s income drops 5 per cent

Products that performed well included Cymbalta (duloxetine), which had a revenue increase of 29 per cent to make $1.07bn during the quarter due mainly to higher demand in international markets.

Profits down for Eli Lilly

Cymbalta (duloxetine) for depression; Alimta (pemetrexed) for non-small cell lung cancer, and type 1 diabetes treatment Humalog (insulin lispro) also had strong quarters with double digit growth.

Lilly wins Cymbalta exclusivity

Cymbalta was originally cleared for marketing in the US in 2004 for the treatment of diabetic peripheral neuropathy. ... Last year, the FDA also approved Cymbalta for the treatment of chronic musculoskeletal pain.

Lilly's Cymbalta approved for new use

Eli Lilly's antidepressant Cymbalta has been cleared by the US Food and Drug Administration for the treatment of chronic musculoskeletal pain. ... This is the fifth indication to be approved for Cymbalta by the FDA.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ahair@onyxhealth.com

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

The doctor will text you now: Why healthcare providers cannot underestimate the importance of communicating change
Healthcare communication needs to switch from ‘transmit’ to ‘receive’, listening to what patients need and embracing the plethora of communication tools wholeheartedly....
How to innovate and influence people in times of misinformation
The pandemic has shown that public trust in promising new medical technologies is far from a given. Senior Writer Tom Vandyck at StoneArch, a member of Fishawack delves into the...
Could femtech be the answer to the gender health gap?
Here, we discuss the phenomenon of femtech, an industry that puts women’s experiences of lifestyle and health front and centre. We highlight some of the major players in the industry,...